Squarepoint Ops »

Rapport Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2025-12-31 $238k 7.9k 30.34
2024-06-30 $380k 16k 23.26

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Broadcom (AVGO)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Semiconductr Etf (SMH)

View all positions for Squarepoint Ops

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics